Please enable Javascript
Wendy Stock, MD
Articles by Wendy Stock, MD
Long-Term Outcomes and Innovations in Frontline ALL
Wendy Stock, MD
Meeting News
|
June 25, 2025
Immunotherapy is reshaping ALL care, and short blinatumomab use may boost outcomes and reduce chemo-related toxicity.
View More
‘The HemOnc Pulse’ Live: What Are the Unanswered Questions in ALL?
Chadi Nabhan, MD, MBA, FACP
The HemOnc Pulse Live
|
May 23, 2024
The panel discussed ALL treatment, associated toxicities, and the possibility of a chemotherapy-free approach.
Listen Now